1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; van Galen, PJ; Williams, M | 1 |
| Borchard, U; Felsch, A; Stöcker, K | 1 |
| Castillo-Meléndez, M; Jarrott, B; Krstew, E; Lawrence, AJ | 1 |
| Haynes, JM; Pennefather, JN | 1 |
| Judd, AM; Krzymowski, DK; Kurth, E; Ritchie, PK; Rossiter, TB; Spangelo, BL | 1 |
| Jarrott, B; Krstew, E; Lawrence, AJ | 1 |
| Kim, YH; Song, DK; Suh, HW | 1 |
| Chandilawa, R; Dagar, S; Gao, XP; Hong, D; Rubinstein, I | 1 |
1 review(s) available for 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
| Article | Year |
|---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
7 other study(ies) available for 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
| Article | Year |
|---|---|
Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Animals; Antihypertensive Agents; Cardiac Pacing, Artificial; Cells, Cultured; Coronary Circulation; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Guinea Pigs; Heart; Heart Rate; Male; Myocardium; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Triazoles; Vasodilation; Ventricular Function, Left; Xanthines | 1994 |
Presynaptic adenosine A2a receptors on soma and central terminals of rat vagal afferent neurons.
Topics: Adenosine; Amino Acids; Animals; Antihypertensive Agents; Antineoplastic Agents; Autoradiography; Brain Stem; Electrophysiology; Ganglionectomy; Male; Microdialysis; Nerve Endings; Neurons, Afferent; Nodose Ganglion; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Solitary Nucleus; Synapses; Vagus Nerve; Xanthines | 1994 |
A1- and A2-purinoceptors in the guinea-pig uterus.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cyclic AMP; Dose-Response Relationship, Drug; Endometrium; Female; Guinea Pigs; In Vitro Techniques; Myometrium; Phenethylamines; Phenylephrine; Phenylisopropyladenosine; Radioligand Assay; Receptors, Purinergic; Theobromine; Uterine Contraction; Xanthines | 1993 |
Adenosine increases interleukin 6 release and decreases tumour necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages.
Topics: Adenosine; Adrenocorticotropic Hormone; Animals; Antineoplastic Agents; Cells, Cultured; Female; Interleukin-6; Macrophages, Peritoneal; Ovary; Phenethylamines; Pituitary Gland, Anterior; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Xanthines; Zona Glomerulosa | 1997 |
Complex interactions between nitric oxide and adenosine receptors in the rat isolated nodose ganglion.
Topics: Adenosine; Animals; Antineoplastic Agents; Diethylamines; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiology; In Vitro Techniques; Male; Neurons, Afferent; Nitric Oxide; Nodose Ganglion; Norbornanes; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Vagus Nerve; Xanthines | 1997 |
Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the mouse.
Topics: Adenosine; Analgesics; Animals; beta-Endorphin; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Phenethylamines; Purinergic P1 Receptor Antagonists; Reaction Time; Theobromine; Xanthines | 1997 |
Adenosine A(1) receptors mediate plasma exudation from the oral mucosa.
Topics: Adenosine; Animals; Bradykinin; Cricetinae; Dextrans; Exudates and Transudates; Fluorescein-5-isothiocyanate; Indomethacin; Male; Mesocricetus; Mouth Mucosa; NG-Nitroarginine Methyl Ester; Nitroglycerin; Phenethylamines; Phenylisopropyladenosine; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theobromine; Xanthines | 2001 |